JPS5855133B2 - 4-amino-3,5-dihalogen-phenylethanolamine - Google Patents
4-amino-3,5-dihalogen-phenylethanolamineInfo
- Publication number
- JPS5855133B2 JPS5855133B2 JP49126469A JP12646974A JPS5855133B2 JP S5855133 B2 JPS5855133 B2 JP S5855133B2 JP 49126469 A JP49126469 A JP 49126469A JP 12646974 A JP12646974 A JP 12646974A JP S5855133 B2 JPS5855133 B2 JP S5855133B2
- Authority
- JP
- Japan
- Prior art keywords
- amino
- formula
- dihalogen
- phenylethanolamine
- dichloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】
本発明は式
(式中、Hal は塩素原子または臭素原子を表わし
、Rはそれぞれ3〜5個の炭素原子を有するアルキル基
またはシクロアルキル基を表わす)で示される4−アミ
ノ−3・5−ジハロケン−フェニル−エタノールアミン
類、並びに無機酸または有機酸の生理学的に許容しうる
その酸付加塩を製造する新規方法に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention provides 4 -Amino-3,5-dihalokene-phenyl-ethanolamines and their physiologically acceptable acid addition salts of inorganic or organic acids.
上記の式■の化合物およびその酸付加塩は価値ある薬理
学的性質、特にβ−受容体に対する活性をもっている。The compounds of formula (1) and their acid addition salts have valuable pharmacological properties, especially activity towards the β-receptor.
驚くべきことに、上記の式■で示される化合物は以下記
載する方法によってすばらしい収率で製造できることが
今回判明した。Surprisingly, it has now been found that the compound represented by formula (1) above can be produced in excellent yield by the method described below.
すなわち式(式中、Halは前記定義のとおりである)
で示される新規化合物、あるいはその水和物を、式(式
中、Rは前記定義のとおりである)で示されるアミン類
の存在下で還元する。That is, the formula (wherein Hal is as defined above)
A novel compound represented by or a hydrate thereof is reduced in the presence of an amine represented by the formula (wherein R is as defined above).
この反応は、溶媒(たとえばメタノール、エタノール、
ジオキサン)中で、あるL・は水分離ろうとを備えた装
置内でベンゼンまたはトルエン中で、あるいはまた、■
式の使用するアミンの過剰量の中で、還元剤、たとえば
触媒により活性化された水素(たとえばラネーニッケル
またはラネーコバルトの存在下の水素)、発生期の水素
(たとえば活性の金属アルミニウムと水、ナ) IJウ
ムアマルガムとエタノール、咥鉛と塩酸)あるいはまた
適当な溶媒(たとえばメタノール、エタノール、エタノ
ール/水、エーテル、テトラヒドロフラン、ジオキサン
、またはジオキサン/水)の存在下に金属水素化物複合
体(たとえば水素化ホウ素ナトリウムまたは水素化リチ
ウムアルミニウム)によって、好ましくは温度O〜11
5℃(たとえば使用する溶媒の沸点までの温度)で、適
切に実施される。This reaction is carried out using a solvent (e.g. methanol, ethanol,
in benzene or toluene in an apparatus equipped with a water separation funnel, or alternatively
In the excess amount of amine used in the formula, reducing agents such as hydrogen activated by a catalyst (e.g. hydrogen in the presence of Raney nickel or Raney cobalt), nascent hydrogen (e.g. activated metallic aluminum and water, ) IJum amalgam and ethanol, lead and hydrochloric acid) or alternatively metal hydride complexes (e.g. hydrogen (sodium boronate or lithium aluminum hydride), preferably at temperatures between 0 and 11
It is suitably carried out at 5° C. (e.g. up to the boiling point of the solvent used).
しかしながら、この反応は、その場で生成した式
(式中、HalおよびRは前記定義のとおりである)で
示される化合物を用いて還元を行なうという方法で実施
してもよL・。However, this reaction may also be carried out in such a way that the reduction is carried out using a compound of the formula (where Hal and R are as defined above) generated in situ.
所望ならば、得られた式■の化合物を無機酸または有機
酸により生理学的に許容される酸付加塩に変えることも
できる。If desired, the obtained compounds of formula (2) can also be converted into physiologically acceptable acid addition salts with inorganic or organic acids.
酸の例として、たとえば塩酸、臭化水素酸、硫酸、リン
酸、乳酸、クエン酸、酒石酸、マレイン酸またはフマー
ル酸が適当であることが判った。Examples of acids that have proven suitable include, for example, hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, lactic acid, citric acid, tartaric acid, maleic acid or fumaric acid.
出発物質として用いる式■の新規化合物は、相当するア
セトフェノン類を二酸化セレンで酸化するか、または相
当する臭化フェナシル類をジメチルスルホキシドで酸化
することによって得ることができる。The new compounds of formula (1) used as starting materials can be obtained by oxidizing the corresponding acetophenones with selenium dioxide or the corresponding phenacyls bromides with dimethyl sulfoxide.
本発明の方法は決して予想することはできなかった。The method of the invention could never have been predicted.
なぜならば、アミノ基とアルデヒド基とを同時に有する
化合物は不安定で、特に塩基の存在下で自己縮合しやす
(・ことが一般に知られているからである。This is because it is generally known that compounds having both an amino group and an aldehyde group are unstable and are particularly prone to self-condensation in the presence of a base.
以下の例によって本発明をさらに説明する。The invention is further illustrated by the following examples.
例 A(参考例)
4−アミノ−3・5−ジクロローフェニルクリオキザー
ル水和物
ジオキサン200Tllおよび水6ml中に二酸化セレ
ン22.2S’を加えた溶液に、60〜70℃にてかく
はんしなから4−アミノ−3・5−ジクロロ−アセトフ
ェノン40.8?を少量づつ加える。Example A (Reference example) 4-Amino-3,5-dichlorophenyl cryoxal hydrate A solution of 200 Tll of dioxane and 22.2 S' of selenium dioxide in 6 ml of water was stirred at 60 to 70°C. So 4-amino-3,5-dichloro-acetophenone 40.8? Add little by little.
4時間還流させてから、この混合物を冷却し、少量の活
性炭を加える。After refluxing for 4 hours, the mixture is cooled and a small amount of activated carbon is added.
この混合物をろ過し、水流ポンプを用いて蒸発させる。The mixture is filtered and evaporated using a water pump.
この残渣を酢酸エチルベンゼン(1:4)に溶解させ、
この溶液が濁るまでシクロヘキサンを加える。This residue was dissolved in ethylbenzene acetate (1:4),
Add cyclohexane until the solution becomes cloudy.
この混合物をろ過し、室温で2時間放置して、4−アミ
ノ−3・5−ジクロロ−フェニルグリオキザール水和物
を徐々に結晶化させる。The mixture is filtered and left at room temperature for 2 hours to slowly crystallize 4-amino-3,5-dichloro-phenylglyoxal hydrate.
融点95〜98℃。例1
1−(4−’LE /−3・5−ジクロロ−フェニル)
−2−tert −ブチルアミノ−エタノールメタノ
ール5omlに4−アミノ−3・5−ジクロロ−フェニ
ルグリオキザール水和物4.l’(0,02モル)を加
え、これをtert −ブチルアミン8.8P(0,1
2モル)に加える。Melting point: 95-98°C. Example 1 1-(4-'LE/-3.5-dichloro-phenyl)
-2-tert-butylamino-ethanol 4-amino-3,5-dichloro-phenylglyoxal hydrate in 5 oml of methanol 4. tert-butylamine 8.8P (0,1
2 mol).
わずかに加熱するとはじめに透明な溶液かえられ、やが
て沈殿してくる。When heated slightly, it initially turns into a clear solution and then precipitates out.
1時間かくはんしてから、水10m1に水素化ホウ素ナ
トリウム1.9 P (0,05モル)を加えた溶液を
滴下し、わずかに加熱するとこの沈殿が溶解しはじめる
。After stirring for 1 hour, a solution of 1.9 P (0.05 mol) of sodium borohydride in 10 ml of water is added dropwise and upon slight heating the precipitate begins to dissolve.
2時間かくはんした後、強い酸性を示すまでこの溶液に
濃塩酸を滴下して水素化ホウ素ナトリウムの過剰分を分
解し、この混合物をろ過し、濃アンモニアでアルカリ性
にす6と1−(4−7ミ/−3・5−ジクロロ−フェニ
ル) 2− tert −7”チルアミノ−エタノ
ールが得られた。After stirring for 2 hours, the excess of sodium borohydride is destroyed by dropping concentrated hydrochloric acid into the solution until it becomes strongly acidic, the mixture is filtered and made alkaline with concentrated ammonia. 7mi/-3.5-dichloro-phenyl)2-tert-7'' thylamino-ethanol was obtained.
収量:4.8?(理論値の866%)、融点110〜1
18℃。Yield: 4.8? (866% of theoretical value), melting point 110-1
18℃.
その塩酸塩の融点174〜1755°C(分解)。The melting point of its hydrochloride salt is 174-1755°C (decomposed).
例2
1−(4−7ミ/−3・5−ジクロロ−フェニル)−2
−シクロプロピルアミノ−エタノール融点125〜12
7℃。Example 2 1-(4-7mi/-3.5-dichloro-phenyl)-2
-cyclopropylamino-ethanol melting point 125-12
7℃.
例1と同様にして4−アミノ−3・5−ジクロロ−フェ
ニルグリオキザール水和物、シクロプロピルアミンおよ
び水素化ホウ素ナトリウムから上記の化合物を製造した
。The above compound was prepared analogously to Example 1 from 4-amino-3,5-dichloro-phenylglyoxal hydrate, cyclopropylamine and sodium borohydride.
例3
l−(4−アミノ−3・5−ジクロロ−フェニル)−2
−シクロブチルアミノ−エタノールその塩酸塩の融点は
184〜1845℃(分解)。Example 3 l-(4-amino-3,5-dichloro-phenyl)-2
-Cyclobutylamino-ethanol Its hydrochloride has a melting point of 184-1845°C (decomposition).
例1と同様にして4−アミノ−3・5−ジクロロ−フェ
ニルグリオキザール水和物、シクロブチルアミノおよび
水素化ホウ素す) IJウムから上記の化合物を製造し
た。The above compound was prepared analogously to Example 1 from 4-amino-3,5-dichloro-phenylglyoxal hydrate, cyclobutylamino and borohydride.
例4
l−(4−アミノ−3・5−ジクロ目−フェニル)−2
−シクロペンチルアミノ−エタノールその塩酸塩の融点
は148〜150℃(分解)。Example 4 l-(4-amino-3,5-dichlorophenyl)-2
-Cyclopentylamino-ethanol Its hydrochloride has a melting point of 148-150°C (decomposed).
例1のようにして4−アミノ−3・5−ジクロローフェ
ニルクリオキザール永和el、シクロペンチルアミンお
よび水素化ホウ素ナトリウムから上記の化合物を製造し
た。The above compound was prepared as in Example 1 from 4-amino-3.5-dichlorophenylclyoxal Eiwa el, cyclopentylamine and sodium borohydride.
本発明は特許請求の範囲に記載の4−アミノ3・5−ジ
ハロゲン−フェニルエタノールアミン類の製造方法であ
るが、次の実施態様を包含する。The present invention is a method for producing 4-amino 3,5-dihalogen-phenylethanolamines as claimed in the claims, and includes the following embodiments.
(1)溶媒の存在下で、温度O〜115℃にて反応させ
る特許請求の範囲に記載の方法。(1) The method according to the claims, in which the reaction is carried out in the presence of a solvent at a temperature of 0 to 115°C.
(2)触媒により活性化された水素、発生期の水素、ま
たは金属水素化物複合体を用いて還元する特許請求の範
囲および上記第1項に記載の方法。(2) The method of claim 1, wherein the reduction is performed using catalytically activated hydrogen, nascent hydrogen, or a metal hydride complex.
(3)式
(式中、HalおよびRは前記定義のとおりである)で
示されるその場で生成上た化合物を用いて還元を行なう
特許請求の範囲に記載の方法。3. A method according to claim 1, wherein the reduction is carried out using a compound of the formula (3) in which Hal and R are as defined above.
Claims (1)
)で示される化合物またはその水和物を、式(式中、R
は、それぞれ炭素原子3〜5個を有するアルキル基また
はシクロアルキル基を表わす)で示されるアミンの存在
下に還元することからなる、式 (式中、Hal およびRは前記定義のとおりである
)で示される4−アミノ−3・5−ジハロゲン−フェニ
ルエタノールアミン並びに無機酸または有機酸との生理
学的に許容しうるその酸付加塩の製造方法。[Scope of Claims] A compound represented by the formula 1 (in the formula, Hal represents a chlorine atom or a bromine atom) or a hydrate thereof is a compound represented by the formula (in the formula, R
each represents an alkyl group or a cycloalkyl group having 3 to 5 carbon atoms), in which Hal and R are as defined above. A process for producing 4-amino-3,5-dihalogen-phenylethanolamine and its physiologically acceptable acid addition salts with inorganic or organic acids.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2354959A DE2354959C3 (en) | 1973-11-02 | 1973-11-02 | New process for the preparation of 4-amino-3,5 dihalo phenyl-athanolamines |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5071637A JPS5071637A (en) | 1975-06-13 |
JPS5855133B2 true JPS5855133B2 (en) | 1983-12-08 |
Family
ID=5897109
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP49126469A Expired JPS5855133B2 (en) | 1973-11-02 | 1974-11-01 | 4-amino-3,5-dihalogen-phenylethanolamine |
Country Status (19)
Country | Link |
---|---|
JP (1) | JPS5855133B2 (en) |
AT (1) | AT340394B (en) |
BG (1) | BG23746A3 (en) |
CA (1) | CA1041545A (en) |
CH (1) | CH609040A5 (en) |
CS (1) | CS175487B2 (en) |
DD (1) | DD116599A5 (en) |
DE (1) | DE2354959C3 (en) |
DK (1) | DK134484C (en) |
ES (1) | ES430587A1 (en) |
FI (1) | FI60858C (en) |
HU (1) | HU168133B (en) |
NL (1) | NL7414223A (en) |
NO (1) | NO139479C (en) |
PL (1) | PL96537B1 (en) |
RO (1) | RO68703A (en) |
SE (2) | SE411546B (en) |
SU (1) | SU549079A3 (en) |
YU (1) | YU36918B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3714484A1 (en) * | 1987-04-30 | 1988-11-10 | Bayer Ag | NEW AMINOPHENYLETHYLAMINE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS A PERFORMANCE PROVIDER |
US5552442A (en) * | 1987-09-15 | 1996-09-03 | The Rowett Research Institute | Therapeutic applications of clenbuterol |
US5530029A (en) * | 1987-09-15 | 1996-06-25 | The Rowett Research Institute | Therapeutic applications of clenbuterol |
US10414717B2 (en) | 2015-08-06 | 2019-09-17 | Vamsi Lab Ltd. | Process for preparing beta agonist |
CN111393311A (en) * | 2020-03-30 | 2020-07-10 | 苏州弘森药业股份有限公司 | Environment-friendly and nontoxic synthesis method of clenbuterol hydrochloride |
-
1973
- 1973-11-02 DE DE2354959A patent/DE2354959C3/en not_active Expired
-
1974
- 1974-09-19 FI FI2736/74A patent/FI60858C/en active
- 1974-09-20 AT AT756374A patent/AT340394B/en not_active IP Right Cessation
- 1974-10-02 ES ES430587A patent/ES430587A1/en not_active Expired
- 1974-10-18 CS CS7165A patent/CS175487B2/cs unknown
- 1974-10-22 DK DK552274A patent/DK134484C/en active
- 1974-10-24 YU YU2850/74A patent/YU36918B/en unknown
- 1974-10-25 SU SU2069690A patent/SU549079A3/en active
- 1974-10-29 BG BG7400028068A patent/BG23746A3/en unknown
- 1974-10-30 DD DD182043A patent/DD116599A5/xx unknown
- 1974-10-30 CH CH1454274A patent/CH609040A5/en not_active IP Right Cessation
- 1974-10-31 RO RO7480380A patent/RO68703A/en unknown
- 1974-10-31 PL PL1974175272A patent/PL96537B1/en unknown
- 1974-10-31 NL NL7414223A patent/NL7414223A/en not_active Application Discontinuation
- 1974-11-01 CA CA212,850A patent/CA1041545A/en not_active Expired
- 1974-11-01 HU HUTO987A patent/HU168133B/en unknown
- 1974-11-01 JP JP49126469A patent/JPS5855133B2/en not_active Expired
- 1974-11-01 NO NO743946A patent/NO139479C/en unknown
- 1974-11-01 SE SE7413786A patent/SE411546B/en not_active IP Right Cessation
-
1977
- 1977-07-28 SE SE7708686A patent/SE430057B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CH609040A5 (en) | 1979-02-15 |
DE2354959C3 (en) | 1980-02-07 |
SE430057B (en) | 1983-10-17 |
YU285074A (en) | 1982-06-18 |
YU36918B (en) | 1984-08-31 |
JPS5071637A (en) | 1975-06-13 |
DD116599A5 (en) | 1975-12-05 |
CS175487B2 (en) | 1977-05-31 |
BG23746A3 (en) | 1977-10-12 |
PL96537B1 (en) | 1977-12-31 |
NO743946L (en) | 1975-05-26 |
DK552274A (en) | 1975-06-23 |
NO139479C (en) | 1979-03-21 |
FI60858C (en) | 1982-04-13 |
HU168133B (en) | 1976-02-28 |
SU549079A3 (en) | 1977-02-28 |
SE411546B (en) | 1980-01-14 |
DK134484C (en) | 1977-04-25 |
NO139479B (en) | 1978-12-11 |
DE2354959A1 (en) | 1975-05-15 |
AT340394B (en) | 1977-12-12 |
FI273674A (en) | 1975-05-03 |
DE2354959B2 (en) | 1979-06-07 |
NL7414223A (en) | 1975-05-07 |
RO68703A (en) | 1981-09-24 |
CA1041545A (en) | 1978-10-31 |
SE7413786L (en) | 1975-05-05 |
FI60858B (en) | 1981-12-31 |
ATA756374A (en) | 1977-04-15 |
DK134484B (en) | 1976-11-15 |
ES430587A1 (en) | 1976-09-01 |
SE7708686L (en) | 1977-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS584713B2 (en) | Imidazolyl-oxime ether and its production method | |
JPS5855133B2 (en) | 4-amino-3,5-dihalogen-phenylethanolamine | |
TW564246B (en) | 3-(1-hydroxy-pentylidene)-5-nitro-3H-benzofuran-2-one, a process for the preparation thereof and the use thereof | |
JPS5924145B2 (en) | Method for producing 1-methyl-3,5-diphenylpyrazole | |
JPH032144B2 (en) | ||
JPH0735374B2 (en) | Novel method for producing piperazine compound | |
JPS60202859A (en) | 3-aminoazetidin compound and manufacture | |
JP2008514554A (en) | Hydrogenation of α, β-unsaturated carbonyl compounds. | |
US3733338A (en) | 1-oxo-isochromenes | |
US3450709A (en) | Process for the preparation of ring-substituted 2-aminoimidazoles | |
JPS6363658A (en) | Manufacture of substituted indolinone derivative | |
KR790001737B1 (en) | New process for the preparation of 4-amino-3,5-dihalogen-phenyl-ethanol amines | |
US3156698A (en) | 2-[alpha-(ortho substituted benzimidoyl) benzyl] pyridine compounds | |
JP4441260B2 (en) | Process for producing 4-amino-4-phenylpiperidines | |
JPH0733374B2 (en) | Phenyl imidazole derivative | |
JPS5944313B2 (en) | Manufacturing method of indazole derivatives | |
JP4082883B2 (en) | Method for producing aziridine derivative | |
JP2664438B2 (en) | Method for producing N- (2-chlorobenzyl) -2- (2-thienyl) ethylamine | |
JPH04217943A (en) | N-(2-amino-3,5-dibromobenzyl)-trans-4-aminocyclohexanol and process for producing same | |
JP3804078B2 (en) | Process for producing β-nitroenamine | |
KR790000942B1 (en) | Process for preparing indazol derivatives | |
Swartz et al. | Synthesis of 2‐(o‐chloropheny)‐and 2‐(2′, 6′‐dichlorophenyl)‐4‐formyl‐1, 2, 3‐triazoles | |
HU202178B (en) | Process for producing aldehyde by hydrogenation of nitryl | |
JPH06501493A (en) | Production method of indole derivatives | |
JPS58154563A (en) | Manufacture of novel benzoxadine |